Dr. Jean-Claude Tardif of the Montreal Heart Institute receives the Research Achievement Award from the Canadian Cardiovascular Society



    MONTREAL, Oct. 30 /CNW Telbec/ - The Montreal Heart Institute (MHI) is
proud to announce that Dr. Jean-Claude Tardif, cardiologist and director of
the MHI Research Centre, professor in the faculty of medicine of the
Université de Montréal, and holder of the Pfizer-Canadian Institutes of Health
Research Chair in atherosclerosis, is the 2008 recipient of the Research
Achievement Award of the Canadian Cardiovascular Society. Instituted in 1982,
this prestigious award is presented to an established researcher whose efforts
are dedicated to a particular aspect of research in the cardiovascular field
in Canada. The award was presented at the 2008 Canadian Cardiovascular
Congress which was taking place in Toronto from October 25 to 29.
    An internationally renowned expert in cardiovascular health,
Dr. Jean-Claude Tardif directs an MHI research team of some 40 people working
in the area of atherosclerosis, the leading cause of death in the world.
Dr. Tardif's approach is three-fold: he works on pharmacological approaches to
raise the level and activity of high-density lipoproteins (HDL or good
cholesterol) and to reduce inflammation in the artery wall, on internationally
recognized pioneering approaches to imaging to precisely assess
atherosclerotic plaque, and on biomarkers, among them the functionality and
composition of HDL to evaluate cardiovascular risk and responses to treatment
for atherosclerosis.
    Pharmacogenomics complements Dr. Tardif's work. He spearheaded the
creation of the first GLP-grade (good laboratory practice) pharmacogenomics
centre in Canada, as well as the MHI Centre of Excellence in Personalized
Medicine aimed at identifying the genomic determinants of drug reactions for a
more personalized approach to medicine.
    Dr. Tardif has authored or co-authored over 500 articles and abstracts
published in scientific journals, among them the New England Journal of
Medicine, the Journal of the American Medical Association, Circulation and
The Lancet. He is also a sought-after guest speaker at conferences in Canada
and abroad; subjects now being addressed by him are atherosclerosis prevention
and regression, and cardiovascular imaging.

    About the Montreal Heart Institute

    Founded in 1954 by Dr. Paul David, the Montreal Heart Institute
constantly aims for the highest standards of excellence in the cardiovascular
field through its leadership in prevention, ultra-specialized care, training
of professionals, clinical and fundamental research, and assessment of new
technologies. It is affiliated with the Université de Montréal and its
outcomes are among the best in the world. To learn more about the Institute,
please visit our website at www.icm-mhi.org.




For further information:

For further information: Julie Chevrette, Communications Consultant,
Montreal Heart Institute, (514) 376-3330, ext. 2641,
julie.chevrette@icm-mhi.org; Doris Prince, Head, Communications and Public
Relations, Montreal Heart Institute, (514) 376-3330, ext. 3074,
doris.prince@icm-mhi.org

Organization Profile

Montreal Heart Institute

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890